--- a
+++ b/clusters/9knumclustersv2/clust_1309.txt
@@ -0,0 +1,17 @@
+Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  weeks prior to study registration
+Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form)
+Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form)
+Investigational drug therapy outside of this trial during or within  weeks prior to CD.
+Investigational drug therapy outside of this trial during or within  weeks of first study treatment
+Excluded therapies and medications, previous and concomitant\r\n* Concurrent anti-cancer therapy (chemotherapy, radiation therapy, surgery, immunotherapy, biologic therapy, or tumor embolization) other than study treatment (regorafenib)\r\n* Prior use of regorafenib\r\n* Concurrent use of chemotherapy, radiotherapy or another investigational drug or device therapy (i.e., outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form)\r\n* Major surgical procedure, open biopsy, or significant traumatic injury within  days before start of study medication\r\n* Use of any herbal remedy (e.g. St. Johns wort [Hypericum perforatum])
+Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  days prior to registration
+Concurrent use of another investigational drug or device therapy (ie, outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form).
+Concurrent use of another investigational drug or device (i.e., outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form)
+Excluded therapies and medications, previous and concomitant:\r\n* Concurrent anti-cancer therapy (chemotherapy, surgery, immunotherapy, biologic therapy, anti-HER targeting therapies, or tumor embolization) other than Ra  dichloride; concurrent external beam radiation therapy is permitted\r\n* Prior use of Ra- dichloride\r\n* Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form)
+Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  days of trial entry (signing of the informed consent form)
+Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form)
+Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form)
+Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form)
+Concurrent use of another investigational drug or device during, or within  weeks of starting study treatment
+Concurrent use of another investigational drug or device during, or within  weeks of starting study treatment
+Concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within  weeks of trial entry (signing of the informed consent form)